The effect of recurrent local anesthetic infiltrations of the anterior and posterior interosseous nerve in chronic wrist pai

Not Applicable

• Conditions: M25; M19; Other joint disorders, not elsewhere classified; Other arthrosis

• Registration Number: DRKS00033418
• Lead Sponsor: BG Klink Ludwigshafen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-02-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

Chronic wrist pain due to traumatic causes for at least three months

Exclusion Criteria

Peripheral nerve diseases, fibromyalgia, complex regional pain syndrome, language barrier, no written consent, refusal of follow-up examinations, ongoing immunosuppressive or antineoplastic therapy, severe cognitive limitations (advanced dementia, acute psychoses, traumatic brain injuries), acute suicidality, surgical treatment of the affected wrist during the intervention period and the subsequent 12-month examination period, contraindications to Scandicain

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary target is pain reduction. The target is assessed pre-intervention, after the fifth and tenth infiltration, and at three post-intervention time points (3, 6, and 12 months). Various assessment methods are planned to capture the primary target pain:<br>•Pain localization: Differentiation between radio-, medio-, and ulnocarpal locations is determined palpatorily by the examiner.<br>•NRS (Numeric Rating Scale): Patients are asked to rate their subjective pain on a scale from 0-100, where 0 represents no pain and 100 represents the worst imaginable pain.<br>•Pain detect: This is a pain questionnaire allowing differentiated information on pain intensity, location, type, and course. The results help estimate the extent to which the pain is based on a neuropathic component.